XW014 / Sciwind Biosci - LARVOL DELTA

XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) (clinicaltrials.gov) - P1 | N=152 | Active, not recruiting | Sponsor: Sciwind Biosciences USA Co., Ltd. | Recruiting ➔ Active, not recruiting

Enrollment closed • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus

XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) (clinicaltrials.gov) - P1 | N=152 | Recruiting | Sponsor: Sciwind Biosciences USA Co., Ltd. | N=104 ➔ 152 | Trial completion date: Aug 2024 ➔ Mar 2025 | Trial primary completion date: Jan 2024 ➔ Feb 2025

Enrollment change • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus

XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) (clinicaltrials.gov) - P1 | N=104 | Recruiting | Sponsor: Sciwind Biosciences USA Co., Ltd.

New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus